Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MARCO antisense RNA 1 (MARCO-AS1) is a putative long non-coding RNA (lncRNA) transcribed from the antisense strand relative to the MARCO gene, but its expression, biological role, and regulatory mechanisms are poorly described in the scientific literature. There is currently no evidence supporting its involvement as a therapeutic target, nor is it recognized as a receptor, enzyme, transporter, or druggable entity. If you are searching for the macrophage receptor with collagenous structure (MARCO), which is a well-known receptor, please use "MARCO" (not MARCO-AS1). If your reference is to another molecule or if there is a new publication on MARCO-AS1, please provide additional context.
No known mechanisms of drug action described for MARCO-AS1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MARCO antisense RNA 1 (MARCO-AS1).